Multiomics Profiling of CSF in Cardiac Arrest Survivors
Key facts
- Who runs it
- Chungnam National University Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 15 people enrolled
- Started
- 22 Jul 2025
- Expected to end
- 31 Mar 2027
- Type of study
- Observational, 2 groups
- Record updated
- 10 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age ≥ 18 years old
- Out-of-hospital cardiac arrest (OHCA)
- Patients who have received post-resuscitation care including temperature control due to unconsciousness (Glasgow Coma Score < 8) after sustained ROSC
- Patients who consented to the placement of lumbar catheter for storing cerebrospinal fluid and blood samples in a human biobank
Who cannot take part
- Patients who have undergone extracorporeal circulatory membrane oxygenation therapy
- Patients diagnosed with a central nervous system-related disease before cardiac arrest
- Patients who died within 24 hours from post-resuscitation care
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to identify further pathophysiologic mechanism of secondary brain injury following cardiac arrest by using serial multiomics profiling of serum and cerebrospinal fluid (CSF) samples. The main question it aims to answer is:
Read full original descriptionShow less
A. The main question it aims to answer is: What are the dynamic molecular changes in serum and CSF that reflect the pathophysiological mechanisms of secondary brain injury after cardiac arrest? B. What are the differences in serum and CSF multiomic signatures between varying severities of cardiac arrest, and how are these differences associated with the underlying pathophysiological mechanisms of secondary brain injury?
Serum and CSF samples that have already been prospectively collected from participants and stored in the BioBank will be used for this analysis.
The 2 groups in the trial
- good neurologic outcome
Cerebral Performance Category (CPC) : 1 or 2
- poor neurologic outcome
Cerebral Performance Category (CPC) : 3 to 5
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Serial Multiomics Profiling Using Serum and Cerebrospinal Fluid Samples Following Out-of-hospital Cardiac Arrest: a Prospective Observational Study
- Record updated
- 10 September 2026